Table 2.
Tumor response
| Variables | RECIST v1.1 | mRECIST | ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
| Overall (n=89) | 1st line (n=49) | ≥2nd line (n=40) | P-value | Overall (n=89) | 1st line (n=49) | ≥2nd line (n=40) | P-value | |
| Initial response | ||||||||
| Complete response | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||
| Partial response | 17 (20.2) | 12 (26.7) | 5 (12.8) | 21 (25.0) | 15 (33.3) | 6 (15.4) | ||
| Stable disease | 38 (45.3) | 18 (40.0) | 20 (51.3) | 34 (40.5) | 15 (33.3) | 19 (48.7) | ||
| Progressive disease | 29 (34.5) | 15 (33.3) | 14 (35.9) | 29 (34.5) | 15 (33.3) | 14 (35.9) | ||
| Not evaluable | 5 | 4 | 1 | 5 | 4 | 1 | ||
| Objective response | 17 (20.2) | 12 (26.7) | 5 (12.8) | 0.115 | 21 (25.0) | 15 (33.3) | 6 (15.4) | 0.058 |
| Disease control rate | 55 (65.5) | 30 (66.7) | 25 (64.1) | 0.805 | 55 (65.5) | 30 (66.7) | 25 (64.1) | 0.805 |